ISSN: 2161-1017
+44 1478 350008
Akankasha Tiwari
Albert Einstein College of Medicine, USA
Posters-Accepted Abstracts: Endocrinol Metab Syndr
The prevalence of pre-diabetes and Type 2; diabetes has increased considerably over the past few decades. The 2014 National Diabetes Statistics report from the CDC reports that 37% of US adults aged 20 years or older have pre-diabetes. Applying this percentage to the entire US population would yield an estimated 86 million American adults with pre-diabetes, with an estimated 50% progressing to frank diabetes within five years. This emphasizes the need to develop and implement effective preventive interventions to curtail the upward trend in diabetes incidence. Recent screening guidelines by the US Preventive Services Task Force advocated screening for pre-diabetes, given the potential for timely interventions to prevent or delay progression to diabetes. It is also been noted that the prevalence of vitamin D deficiency has increased over the past few decades, likely due to such lifestyle changes as sunscreens, diminished outdoor activities and decreased milk intake. In various areas of the US, an estimated 30% of individuals may be vitamin D deficient or insufficient. There has been considerable recent attention surrounding a potential link between vitamin D deficiency and metabolic disease. Recent studies suggest that correcting vitamin D deficiency in obese individuals with pre-diabetes reduces the likelihood of developing type 2; diabetes. Given the increasing prevalence vitamin D deficiency and pre-diabetes, there is an urgent need to implement new therapeutic interventions aimed to prevent progression from pre-diabetes to diabetes.
Email: akgoyal@montefiore.org